Table 1.

Characteristics of 53,859 Women Without Prior ART Treatment Undergoing ART in New York Texas, and Illinois between 2004 and 2009

	All	Women	Women	Person-years	P Value*
	Women	Without Cancer	With Cancer	Of Follow-up	Between groups
(N)	53,859	53,409	450	262,309
Age at cancer diagnosis (mean years, SD)			40.8 ± 5.7
Age at Start of ART Treatment (mean years, SD)	35.3 ± 5.3	35.3+5.3	37.8 ± 5.4		<0.0001
(%) <30	14.4	14.4	7.1	38,841
31-34	30.0	30.1	19.1	81,164
35-37	20.4	20.4	19.6	54,091
38-40	17.7	17.7	24.4	44,910
41-42	11.8	11.8	16.4	29,477
≥43	5.7	5.7	13.3	13,826
(%) Parity
0	77.5	77.6	74.9	202,859	0.27
1	14.1	14.0	16.7	37,289
≥2	8.4	8.4	8.4	22,161
Infertility Diagnosis (%), more than one is possible
Male factor	32.8	32.8	31.8	86,981	0.69
Endometriosis	9.1	9.2	8.4	25,379	0.68
PCOS	12.7	12.7	10.7	35,538	0.91
Diminished Ovarian Reserve	22.2	22.1	31.1	54,714	<0.0001
Tubal factors	20.2	20.2	17.1	54,322	0.11
Uterine factors	5.2	5.2	6.2	13,267	0.34
Other factors	14.9	14.9	20.9	39,626	0.0007
Unexplained	12.3	12.4	10	32,837	0.15
(%) Number of Diagnoses
1	75.3	75.4	70.4	195,396	0.02
>1	24.7	24.6	29.3	66,913
Number of Cycles (%)
1	51.1	51.1	48	126,957	0.45
2	26.1	26.2	25.6	69,729
3	12.4	12.4	14.7	34,680
4	5.5	5.5	6.4	16,259
≥5	4.9	4.8	5.3	14,684
Cumulative dose of FSH Stimulation (%)
none	7.7	7.7	12.2	20,017	0.0003
<2,000 IU	19	19.0	14.4	49,525
2,000-3,999 IU	29.8	29.9	26	76,791
4,000-6,999 IU	21.6	21.6	22.4	56,061
7,000+ IU	21.8	21.8	24.9	59,915
ART Outcome: Live birth	49.1	49.2	44.4	132,594	0.12
Conception, no live birth	7.5	7.5	8.9	19,459
No conception	43.3	43.3	46.7	110,256

^*P-values calculated from chi-square test or two-sample t-test (age)